Meng Wei
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Safety and efficacy of salvage surgery for unresectable hepatocellular carcinoma after conversion with triple therapy: a systematic review and meta-analysis of data from Chinese patients.
Journal: World journal of surgical oncology
Published: July 24, 2025
Predicting recurrence and recurrence-free survival in initially unresectable hepatocellular carcinoma: a novel nomogram for patients undergoing conversion hepatectomy with lenvatinib, PD-1 inhibitor, and interventional therapy.
Journal: Frontiers in immunology
Published: March 29, 2025
Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors.
Journal: Frontiers in cellular and infection microbiology
Published: March 22, 2025
GP73-dependent regulation of exosome biogenesis promotes colorectal cancer liver metastasis.
Journal: Molecular cancer
Published: January 03, 2025
Ubiquitination of P53 Regulated by Ubiquitin-Specific Protease 14 Delays the Invasion of Hepatitis B Virus and the Development of Hepatitis.
Journal: Viral immunology
Published: November 27, 2024
The Role of Timing of Progression and Early Salvage Surgery in Unresectable Hepatocellular Carcinoma Treated with TACE Plus TKIs and PD‑1 Inhibitors.
Journal: Journal of hepatocellular carcinoma
Published: June 07, 2024
TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study.
Journal: BMC cancer
Published: December 10, 2023
Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study.
Journal: Langenbeck's archives of surgery
Published: October 12, 2023
Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation.
Journal: International journal of nanomedicine
Published: June 22, 2023
External quality assessment for detection of methylated Syndecan 2 (SDC2) in China.
Journal: Clinical chemistry and laboratory medicine
Published: March 06, 2022
Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
Journal: Translational cancer research
Published: October 02, 2019
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 09, 2018
Last Updated: 09/26/2026